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Abstract
Endotracheal intubation is an intervention frequently performed in the hospital setting in
order to protect the central airway and provide mechanical support of ventilation. Many
health care providers are expected to be able to intubate the patients for different indica-
tions. As the case in any medical intervention, endotracheal intubation can cause compli-
cations. These complications are categorized as early or late according to the time of onset
of the presenting symptoms. This chapter will discuss the long term complications of
endotracheal intubation that might be encountered by the treating physicians. The chapter
will stress on the predisposing factors for these complications and the available methods
to avoid and treat them.
Keywords: intubation related complications, obstructive fibrinous tracheal
pseudomembranes, post-intubation tracheal stenosis, tracheomalacia, tracheoesophageal
fistula
1. Introduction
Intubation is an invasive, however, lifesaving procedure which established its role in the daily
management of critically ill patients. Physicians treating patients with endotracheal tubes can
encounter complications during or immediately after the procedure. Complication appearance
or identification can be delayed for days to weeks. They can be categorized into three categories:
1. Long term complications that occur immediately during endotracheal tube (ETT) insertion
2. Complications of the prolonged intubation
3. Late onset complications
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2. Risk assessment and general preventive measures
Risk assessment and preventive measures of the intubation-related complications should be
undertaken immediately after the decision for an endotracheal tube (ETT) insertion is taken for
the patient’s management. These measures can be divided into three main groups:
I. Measures that should be taken before intubation:
1. Routine assessment for potentially difficult intubation cases.
2. Choosing the proper sized tube.
3. Using proper technique
4. Choose an experienced, skilled physician to perform the procedure.
5. Preparing alternative plans in cases of unanticipated difficulties. The Difficult Airway
Society (DAS) guidelines recommended a four steps plans A–D as the following [1]:
A. Preparing an initial tracheal intubation plan that includes using the direct laryn-
goscopy.
B. Preparing a secondary intubation plan which includes using a dedicated
supraglottic airway device such as the classic laryngeal mask airway (LMA) in
case of plan A has failed.
C. When plan B fails; the physician should be prepared to oxygenate and ventilate
the patient, postpone the surgery, and awaken the patient.
D. In cases where physician ‘cannot intubate, cannot ventilate’ (CICV) rescue tech-
niques such as cannula or surgical cricothyroidotomy should be available at the
facility.
II. Measures that applied during intubation:
1. Intubating the patients under direct vision.
2. Using intubation assisting devices as the ETT stylet, Eschmann tracheal tube intro-
ducer (gum-elastic bougie tube), video laryngoscope or the flexible bronchoscopy in
difficult to intubate cases [2].
3. Applying appropriate cuff pressure not to exceed 20 mm H2O.
4. Stabilization the ETT using fixation tapes or devices.
III. Measures which should be applied after intubation:
1. Frequent suctioning of the oral and endotracheal secretions.
2. Application of antiseptics as chlorhexidine to decontaminate the oral cavity.
3. Assessments of skin integrity around lips and adhesive tape at least twice daily.
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3. Complications that occur immediately during endotracheal tube (ETT)
insertion
Complications of tracheal intubation might occur at any stage during the intubation with
devastating consequences which may last as long as patients survive.
Table 1A lists the chronic complications that usually result from trauma during intubation.
3.1. Post intubation prolonged voice hoarseness
Temporary hoarseness is a common complain that occur in one third [3] to half [4] of the
intubated patients and usually resolve spontaneously within 1 week; however, the incidence
of prolonged hoarseness (>7 days) is estimated to be less than 1% [4, 5]. Vocal cord edema or
lacerations, epiglottic hematoma and vocal cord paralysis secondary to compression of ante-
rior branch of the recurrent laryngeal nerve are all potential etiologies of prolonged hoarseness
[6]. In a prospective study 7 out of 25 cases (28%) of prolonged hoarseness had no identifiable
causes [4]. Permanent hoarseness is even more rare, and being caused by granuloma of the
vocal cord or arytenoid dislocation. The risk factors for this complication found to be longer
duration of intubation, older age [4] and female gender [7]. Using a smaller size tube especially
for females has been suggested to decrease the incidence of prolonged voice hoarseness [4, 8].
3.2. Arytenoid dislocation
Arytenoid dislocation is a rare cause of vocal cord paralysis with less than 0.1% incidence rate
[9]. The commonest mechanism of intubation related vocal cord paralysis is compression of the
anterior branch of the recurrent laryngeal nerve as a result of prolonged intubation which will
be discussed separately under complication of prolonged intubation subtitle. Risk factors for
this complication can either be related to patients or the procedure. Patients related factors
include retrognathia, dental malocclusion, a large tongue base, and cricoarytenoid joint
involvement by rheumatoid arthritis. While; Procedure related risk factors include traumatic
and/or prolonged intubation, protrusion of the endotracheal tube stylet, pressure from the
distal curved part of the ETT and inexperience and poor techniques by the performance [10].
The majority of the patients present with dysphagia [11]; prolonged hoarseness, sore throat,
and cough are less frequent symptoms. There are two types of dislocation, the posterolateral
and the anteromedial dislocation; the latter being the most dangerous as it can compromise the
Prolonged voice hoarseness
Arytenoid dislocation
Cervical spine and spinal cord injuries
Traumatic dental injury
Table 1A. Chronic complications that occur immediately at ETT insertion.
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airway causing acute stridor and acute respiratory distress soon after extubation [12]. Figure 1
shows example of anteromedial left arytenoid cartilage dislocation [13].
Diagnosis can be confirmed by laryngoscopy and/or CT scan [14]. Laryngeal electromyogra-
phy is sometimes used to differentiate arytenoid dislocation from recurrent laryngeal nerve
paralysis. Tracheotomy is required in cases which present with acute airway compromise,
other cases may have spontaneous repositioning of arytenoid cartilage thus do not need
treatment [15]. Many surgical laryngoscopic techniques have been described as the definitive
treatment [16, 17]. Late treatment options include Teflon injection, cricoarytenoid arthrodesis
[18] and laryngeal framework procedure [19].
3.3. Cervical spine and spinal cord injuries
Urgent intubation to ensure protection of the airways is frequently required for poly-trauma
patients. Careful manipulation of the neck by an experience health care provider is of crucial
importance as such patients potentially have cervical spine injuries. Predictors of spinal injury
in poly-trauma cases are accident by motor vehicle collision or fall down. Presence of pelvic
fracture or Injury Severity Score (ISS) >15 should alert the physician to a possible cervical spine
involvement [20]. Patients with systemic diseases which potentially affect the cervical spine as
rheumatoid arthritis or ankylosing spondylitis must be handled as high risk for intubation
related cervical spine injuries. Once the health care provider suspects a high risk cervical spine
injury, he should maintain the patient’s head in a neutral position throughout the intubation
procedure. Cervical hyperextension in such cases can traumatize the spinal cord resulting in
paraplegia. Manual In-Line Stabilization (MILS) is the recommended method to stabilize the
head and neck during high risk intubation. The caveats of this method are: firstly, the need of a
second health care provider who stabilizes the patient’s occiput and mastoid processes using
his both hands. Secondly, it decreases the laryngoscopic view by 45% [21]. Application of
cervical collar is another important protective measure; available collars include soft collar,
hard collar, extrication collar, Philadelphia collar. Again, application of collar significantly limit
mouth opening and make intubation harder [22]. Cervical spine can also be stabilized using a
bilateral sandbags with 3-inch-wide cloth tape across the forehead. Adding Philadelphia collar
to the sand bags further reduced the extension movement [23].
Figure 1. Laryngoscopic image of anteromedial dislocation of left arytenoid cartilage. Courtesy of Oh et al. [13].
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In cases of difficult intubation the available choices are:
1. Video or fiberoptic laryngoscopy intubation.
2. Gum elastic bougie which has been shown in a clinical study to facilitate the intubation
while applying MILS [21].
3.4. Traumatic dental injury
The incidence of traumatic dental injury found to be 1:2805 in a large analysis of more than 500
thousand surgeries. The most common tooth to be traumatized is the upper incisors; further-
more, 13% of the cases had multiple teeth involved. Different type of teeth injuries have been
described, crown fracture and partial dislocation being the commonest [24]. Difficult intuba-
tion is the main risk factor for dental injury, other risk factor include poor dentation and
preexisting craniofacial abnormalities [24].
4. Complications of the prolonged intubation
Prolonged intubation is defined as intubation exceeding 7 days [25]. Clinical studies have
shown that prolonged intubation is a risk factor for many complications.
Table 1B lists complications of prolonged intubation that present while patient is still on
mechanical ventilator or early at extubation.
4.1. Mucosal/dermal pressure ulcer
Mucosal/dermal pressure ulcers are caused either by the tube itself or by the securing taps and
devices. It can affect the lips, mouth, gums, and tongue. This complication is very common
despite it is preventable; its incidence reported to be 20% in mechanically ventilated patients
[26]. The identified risks for pressure ulcer are [27, 28]:
1. Hypoalbuminemia, older age, catabolic diseases.
2. Increase pressure, shearing forces and friction over bony prominence.
3. Moisture.
Pressure ulcer around adhesive tapes
Vocal cord paralysis
Ventilator-associated pneumonia (VAP)
Sinusitis
Tracheomalacia
Laryngotracheal stenosis
Table 1B. Complications of prolonged intubation.
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Prevention of ETT related pressure ulcer can be summarized in the following steps [29]:
1. To Proper size of the tube before the insertion.
2. To adequately secure the tube to prevent dislodgment without creating additional pressure.
3. To inspect the skin beneath the tube at least twice daily.
4. To keep the skin under the tube dry and clean as possible.
5. To reposition the ETT to redistribute pressure while make sure that the ETT depth did not
change.
6. To remove the tube once it is not absolutely necessary.
Pressure ulcers prevention is crucial as they are painful and their healing process is slow.
Generally, removal of the cause of the pressure, cleaning, application of antiseptics and debride-
ment is the available treatment options.
4.2. Vocal cord paralysis
Intubation related vocal cord paralysis is rare with estimated incidence of 0.03%; nevertheless, it
constitutes 22.6% of all causes of vocal cord paralysis [30]. It is usually a result of compression of
the anterior branch of the recurrent laryngeal nerve between the inflated cuff of the ETT and the
thyroid cartilage [31]. Prolonged intubation is the major risk factor for vocal cord paralysis which
can be unilateral (left vocal cord is more commonly involved than the right) or bilateral [6].
Unilateral vocal cord paralysis present immediately after extubation with hoarseness of voice
and dysphonia; while, bilateral paralysis presented as sever stridor which lead to reintubation.
Re-establishment of vocal cord motion is a good prognostic sign of improvement of the voice
[32]. In bilateral vocal cord palsy pulmonary function testing shows variable extrathoracic
obstruction on flow volume loop [33]. Direct laryngoscopy and/or laryngeal electromyography
are the diagnostic test of choice. Intervention is not required for unilateral paralysis as spontane-
ous resolution usually occurs on average of about 10 weeks [6], however, if no resolution occurs
in 12 months then recovery is unlikely [32]. Temporary injection of the affected vocal cord is an
option to improve the voice [32]. Unfortunately, tracheostomy is necessary in many cases suffer-
ing from bilateral vocal cord paralysis for long term management.
4.3. Ventilator-associated pneumonia (VAP)
Ventilator-associated pneumonia (VAP) is defined in the latest Infectious Diseases Society of
America (IDSA) and the American Thoracic Society (ATS) guideline as a pneumonia occurring
>48 h after endotracheal intubation [34]. VAP is subsequently divided for practical reasons in
to an early onset pneumonia and late-onset pneumonia; the earliest is a pneumonia that
develops within the first 4 days of admission in the mechanically ventilated patients [35]. A
systematic review has estimated that between 10 and 20% of patients receiving >48 h of
mechanical ventilation develop VAP [36]; up to 50% of them develop an early VAP (within
the first 4 days after admission) [35]. Interestingly, the VAP hazard is decreasing over days,
this has been shown in a prospective multicentre Canadian study where VAP rate was approx-
imately 3% per day in the first week of mechanical ventilation, then the rate dropped to 2%
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and 1% per day in the second and the third week respectively [37]. Gastric colonization,
oropharyngeal and tracheal colonization, and cross colonization of the patients by contami-
nated hands of hospital personnel are all risks for VAP. Endotracheal tubes itself appear to be
an independent risk factor for VAP [38]. Its presence impairs the host natural defenses against
infections; furthermore, bacteria adhere to the plastic tube forming a complete or partial
biofilm in 84 and 95% respectively [39]. Intubated patients are having recurrent aspirations of
dislodged parts of this biofilm or from the pooled secretions above the tube cuff.
Studies have shown that the bacterial colonization is changed from community to nosocomial
pattern after the fourth day of the admission [34]. In early-onset pneumonia the commonest
pathogens include, Streptococcus pneumoniae, Haemophilus influenzae and methicillin sensitive
Staphylococcus aureus (MSSA); while in the late onset methicillin resistant Staphylococcus aureus
(MRSA), Gram-negative bacilli such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella
pneumoniae, and Acinetobacter baumannii are frequently encountered [40]. Moreover, it is not
uncommon for VAP to have polymicrobial infection. VAP diagnosis is achieved by using the
following diagnostic criteria [41]:
1. Clinical sign of infection as fever, purulent tracheal secretions, and leucocytosis.
2. Bacteriologic evidence of infection.
3. Radiologic suggestion of infection.
Application of strict prevention measures in the intensive care units is practical approach to
deceases the burden of VAP on the patients and the health care system. VAP prevention mea-
sures include:
1. Noninvasive positive-pressure ventilation in selected groups of patients.
2. Silver covered tube: it has been shown in a Cochrane review that silver coated tube decrease
the risk of VAP in the first 10 days of mechanical ventilation possibly due to the antimi-
crobial effect of silver [42].
3. Mouth hygiene with chlorhexidine as a mouthrinse or a gel: this has shown in a Cochrane
review to reduce the risk of VAP from 24% to about 18% [43].
4. Positioning the patient in semirecumbent position: decrease the risk of VAP from 35 to 8%
comparing to supine position [44].
5. Applying an endotracheal tube cuff pressure of 20 cm H2O to prevent aspiration.
6. Continuous aspiration of subglottic secretions (CASS): it reduce both early and late onset VAP [45].
7. Discontinuation of mechanical ventilation as early as possible.
IDSA/ATS updated guideline recommends empirical coverage of both S. aureus and P. aeruginosa
in patients with suspected VAP. They recommended either vancomycin or linezolid to cover
MRSA in at risk patients or in patients who are treated in units with high methicillin resistant
rate (>10–20%). Single antipseudomonal antibiotic is generally suggested unless the patient is at
high risk for antimicrobial resistance or being treated in a unit with high resistant rate for
pseudomonas (>10%). A 7-day course is generally recommended [34].
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4.4. Sinusitis
Incidence of nosocomial sinusitis is estimated to be 12 cases per 1000 patient-days [46]. Prolonged
intubation is the main risk factor as the majority of the infections occur after 7 days of the
hospitalization [47]. The rout of intubation either orotracheal or nasotracheal does not alter the
nosocomial sinusitis rate as shown in a randomized clinical trial of patients needed intubation for
more than 7 days [48]. Other identified risk factor include sedative use, nasoenteric feeding tube,
Glasgow Coma Score (GCS) less than 7 and nasal colonization with Gram-negative bacteria [46].
Nosocomial sinusitis usually presents with fever; the disease should be suspected in all intubated
patients who have a fever without an obvious source. Most patients have leucocytosis [47];
purulent nasal discharge is a useful clinical sign that raise the suspicion of the sinusitis as a source
of the infection. Air-fluid level or opacification are the radiological signs seen on the sinus CT
scan images. Microbiological confirmation of the infection can be achieved by culture of sinus
fluid in 75 and 90% of the cases using antral tap or endoscopic tissue culture respectively [49].
Infective bacteria that cause nosocomial sinusitis are similar to those of VAP, furthermore, up to
62% of patients with confirmed sinusitis had evidence of concomitant ventilator associated
pneumonia (VAP); thus, assessment for VAP is warranted [50]. Nosocomial sinusitis requires 5–
7 days of empirical broad spectrum systemic antibiotic that cover the common hospital acquired
pathogens until the result of the sinus fluid culture is available [51]. Additional local measures
include removal of nasogastric tubes and using nasal decongestants [51]. Surgical drainage of the
infected sinuses is indicated if the condition failed to response to the appropriate course of
antibiotic therapy within 2–5 days of treatments [51].
5. Late onset complications
In this sectionwe discuss the complicationswhich usually present days toweeks after extubation.
Many of the late onset complications are consequences to prolonged intubation. Table 2 summa-
rizes the late onset complications.
5.1. Obstructive fibrinous tracheal pseudomembrane
Formation of an obstructive fibrinous tracheal pseudomembrane (OFTP) is a rarely reported
but potentially fatal complication. OFTP has been reported in 53 patients (39 adult and 15
Obstructive fibrinous tracheal pseudomembrane formation
Post-intubation tracheal stenosis
Laryngeal stenosis
Tracheomalacia
Tracheoesophageal fistula
Tracheoarterial fistula
Table 2. Late onset complications.
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pediatric) until September 2016 [52]. The OFTP is not just a thick mucus plug that impact on
the tracheal wall; it is a well-formed, well-organized fibrinous membrane.
The exact mechanism of this fibrinous material formation is not completely known. It is hypothe-
sized that OFTP is a consequences of tracheal ischemic injury which lead to mucosal injury. This
cause desquamation and necrosis of the tracheal epithelium in addition to polymorphonuclear cells
infiltration; and subsequently fibrinous material formation [53, 54]. OFTP has been reported in
patients intubated with different types of ETT including cuffed rubber tubes, double lumen tube,
and cuffed and uncuffed silicone tubes. Clinical studies have suggested several risk factors such as
increase pressure of ETT cuff, usage of large tracheal tubes, traumatic intubation and prolonged
intubation [54]. Presence of one or more of the previously mentioned risk factors is not absolutely
necessary forOFTP to develop. Patients havingOFTPmost commonly presentwith post extubation
stridor, cough and/or hoarseness with 74.1%, 13% and 9.3% respectively. Respiratory failure may
develop in almost one third of the cases. Themedian time to onset of symptoms after extubationwas
30 h in adult population. Nevertheless, OFTP is still in the differential diagnosis for early extubation
failure; it has been presented immediately after extubation in few cases [52]. CT scan can show the
intratracheal pseudomembrane, however, the definitive diagnosis is usually obtained by flexible
bronchoscopy. Spontaneous expulsion of the fibrinous tracheal pseudomembrane is uncommon
(11.1%), and flexible bronchoscopy is a very useful option for removal of the pseudomembrane
especially in the pediatric population. Rigid bronchoscopy is another important tool which was
reported to be necessary for a successfulmanagement inmore than 50%of the adult patients [52].
5.2. Post intubation tracheal stenosis (PITS)
The incidence of PITS was previously estimated to occur in 1% of the intubated patients;
however, the use of low pressure high volume cuffs has reduced its incidence by 10-fold [55].
The pathogenesis of PITS starts by a mucosal ischemic injury due to excessive ETT cuff pressure
(>30 mm Hg) [56]. This compression injury on the tracheal cartilages causes chondritis with
subsequent cicatricial fibrosis and progressive stenosis [57]. Figure 2 shows the ETT cuff related
compression injury in a canine module [58].
Figure 2. A. Congestion of the external tracheal wall compressed by cuff was observed immediately after extubation. B.
Tracheal cartilage underwent necrosis and collapsed at 2 weeks after extubation. Courtesy of Su et al. [58].
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PITS is categorized into three types [55]:
1. Simple (web-like) stenosis (Figure 3A and D):
• The length is less than 1 cm
• No or minimal damage to tracheal cartilages.
2. Complex stenosis (Figure 3B and E):
• Longer than 1 cm.
• Tracheal cartilages are damaged.
• Usually complicated with tracheomalacia.
3. Pseudoglottic (A-shaped or tent-shaped) stenosis (Figure 3C) [59]:
• It is a particular subtype of the complex stenosis that usually follows tracheostomy
insertion.
• The stenosis is due to dislocation or fracture of the tracheal cartilaginous rings with
localized tracheomalacia
Increased ETT cuff pressure is considered to be the most important cause of PITS;
other proposed risk factors are [60]:
1. Oversizing the ETT in comparison to the tracheal lumen.
2. Prolonged intubation. It should be noted that a brief intubation does not exclude the
diagnosis of PITS as it has been reported to follow intubation of less than 24 h [61].
Figure 3. A–C: Bronchoscopic images show the different types of the PITS (G. Stratakos; Intubation/Long-Term Compli-
cations of Tracheal Intubation). D and E: Schematic illustration of simple and complex PITS on coronal cut of chest CT (A.
Touman; Intubation/Long-Term Complications of Tracheal Intubation).
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3. Hypotension
4. Steroid use and local tracheal infection are potential risk factors.
Patients with PITS usually complain of dyspnea with or without stridor. Expira-
tory wheeze at exertion is also a feature of PITS which can be easily confused with
asthma. Therefore, the diagnosis is not initially suggested in up to 44% of the
cases [56]. Furthermore, PITS manifest lately during patients’ recovery from the
ICU admission; during which patients’ physical activity is minimal. Thus dys-
pnea and stridor may not be clinically evident until the disease reaches an
advanced stage i.e. trachea has lost 70% of its diameter [55, 62].
PITS symptoms usually start within the first 3 months after extubation. The
stenotic segment can be visualized by the computed tomography or directly
during bronchoscopy. If pulmonary function test is requested the characteris-
tic plateaued expiratory curve of the flowvolume loops exhibit only if the
tracheal lumen is critically stenosed [55]. Management of PITS requires a
multidisciplinary approach including thoracic surgeon and interventional pul-
monologist experience in the treatment of such cases. Simple web-like steno-
ses can be treated by radial incisions at 3 and 9-o’clock positions using
neodymium-yttrium aluminum garnet (Nd-YAG) laser, photo-dissection or
electro-knife [63]. Circumferential sleeve resection with end to end anastomo-
sis is the treatment of choice if applicable for the Complex stenosis and in
cases of multiple relapses of the web like stenoses. In non-operable patients
balloon dilatation, Nd-YAG laser, photo-dissection and/or stent placement are
alternative options [55].
5.3. Tracheomalacia
Malacia derives from the Greek world “μαλακία”which means softness. Tracheomalacia (TM)
describes the condition where the anterolateral wall of the trachea collapses during respiratory
cycle due to softening of the cartilaginous rings that maintain the contour of the trachea. If the
disease extends to involve the trachea and the main bronchi the term tracheobronchomalacia
(TBM) is used. In cases where the posterior membranous part of the trachea excessively
displaces anteriorly during expiration as a result of atrophy of the longitudinal elastic fibers
of the membranous wall, the condition is described as excessive dynamic airway collapse
(EDAC) [64]. TM and EDAC may or may not coexist [65].
The tracheal lumen caliber normally varies during the respiratory cycle; decrease in the cross-
sectional area of the trachea by more than 50% is considered abnormal [66]. Tracheomalacia
may results from primary (congenital) or secondary (acquired) causes;
The exact incidence of the TM after intubation is unknown; in general the acquired TM
is more common than the congenital one [64]. Intubation and tracheostomy are the
commonest secondary causes [66]. Risk factors and the pathogenesis of the TM are similar
to PITS where the tracheostomy stoma or the excessive and/or prolonged ET tube cuff
pressure causes airway ischemia and chondritis which eventually result in necrosis and
softening of the tracheal cartilage [66]. Depending on the site of the insult TM can be
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intrathoracic or extrathoracic; the intrathoracic (below the thoracic inlet) tracheomalacia
being the commonest. In cases of intrathoracic tracheomalacia the trachea collapses during
expiration because the intrathoracic pressure exceeds the intraluminal pressure; while in the
extrathoracic tracheomalacia the collapse occur during the inspiration because the atmo-
spheric pressure exceed the negative intratracheal pressure [67].
TM might be overseen if the tracheal narrowing is mild; On the contrary, it can be diagnosed
early in case of difficulty to wean a patient from mechanical ventilation [6]. Intubation itself
can pose diagnostic challenges for diagnosis because the ETT keeps the malacic part of the
trachea patent preventing its collapse. Moreover, the positive-pressure ventilation acts as a
pneumatic stent [65]. In milder cases, exertional dyspnea, cough, difficulty to clear sputum and
hemoptysis are the main symptoms [68]. Barking cough [69] and cough syncope [70] associ-
ated with forced cough are also feature of the disease. In severe cases of TM symptoms can
progress to hypercapnic (type 2) respiratory failure [71]. Inspiratory and/or expiratory stridor
presence depends on the severity of the collapse and the location of the malacic tracheal
segment. As was the case with PITS, TM poses diagnostic challenge due to overlap between
its symptoms and asthma symptoms. In fact, dyspnea associated with wheeze is present in
51% of TM cases which frequently misdiagnosed as bronchial asthmas. Moreover, physician
might confuse the recurrent episodes of bronchitis which result from the retained secretions by
asthma exacerbation. History of ET intubation or tracheostomy should alert the treating
physician to consider TM especially if the patient condition is refractory to corticosteroids and
bronchodilators therapy [65].
Once TM is suspected a dynamic airway CT scan (during inspiratory and expiratory phase)
can confirm the diagnosis. The dynamic flexible bronchoscopy preferably performed on spon-
taneously breathing patients under conscious sedation is considered the gold standard diag-
nostic method (Figure 4) [72]. Cine fluoroscopy and Cine magnetic resonance imaging are
alternative methods for diagnosis.
Different abnormalities on the pulmonary function test can suggest the TM, however, none are
characteristic. The reported abnormalities include:
Figure 4. Bronchus intermedius with severe bronchomalacia, before and after establishment of C-PAP non-invasive
mechanical ventilation (G. Stratakos; Intubation/Long-Term Complications of Tracheal Intubation).
Tracheal Intubation100
1. The commonest abnormality is an obstructive lung physiology with decreased value of
forced expiratory volume in 1 s (FEV1); it was reported to occur in approximately 70% of
the cases [73].
2. Flattening of the expiratory limb of the flow volume curve. This pattern is highly suggestive of
TM and it was recorded in 50% of the moderate severity cases [73].
3. The flow-volume loop shows rapid declines of the maximal expiratory flow following a sharp low
peak [74] Figure 5.
4. Rarely, flow oscillations (saw-tooth appearance) appear on the flow volume curve (observed in
1.4% of the cases) [75, 76].
Incidental discovery of TM or EDAC during bronchoscopy in asymptomatic patients does not
require medical intervention. Available treatments for the symptomatic cases include:
1. Noninvasive positive-pressure ventilation (NIPPV) using Continues positive airway pressure
(CPAP) which act as pneumatic splint for the malacic collapsing airway [65].
2. Bronchoscopic interventions and stent placement are one of the most commonly used treat-
ment options in TM. Silicone stents are preferred because of the dynamic nature of the
airway during breathing. Patients should be aware of the need of continues care of the
stent to prevent obstruction of the stent by retained mucus [65].
3. Tracheostomy which bypasses the malacic segment; if a longer tube used as Montgomery
T-tube the tube itself splint the airway open. In cases of long malacic segment it can be
combined with the NIPPV [64].
Figure 5. A. The flow volume loop of a post intubation TM patient shows rapid decline in the maximal expiratory
flow after a sharp peak. B. Flow volume loop of the same patient after treatment with tracheal silicon stent (G.
Stratakos; Intubation/Long-Term Complications of Tracheal Intubation).
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4. Surgical interventions such as:
a. Tracheal resection and end to end anastomosis can be curative in short segment
tracheomalacia [77].
b. Tracheobronchoplasty: different surgical methods have been described to reinforce the
wall of the malacic trachea; surgeon used mesh, autologous grafts from fascia, bone or
costal cartilage as tracheal splint. Biocompatible ceramic rings and plastic prostheses
have also been used [64].
5.4. Tracheoesophageal fistula
Development of a tracheoesophageal fistula (TEF) in an intubated is rare; it is estimated to
occur in less than 1% of the intubated patients [78]. High ETT cuff pressure is the major cause
of this complication, it cause the tube to erode through the posterior membranous part of the
trachea in to the esophagus forming a communicating tract Figure 6.
Ischemic necrosis starts to appear after as little as 10 h of intubation with ETT cuff pressures of
greater than 20–30 cm of water [78]. Other risk factors of TEF include [79]:
1. Prolonged duration of intubation.
2. Excessive repeated ETT manipulations.
3. Use of a rigid nasogastric tube
Figure 6. Illustrates a TEF shown during bronchoscopy. Arrow is pointing the orifice of the esophageal fistula (Gr. Stratakos;
Intubation/Long-Term Complications of Tracheal Intubation).
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4. Diabetes, infection and/or steroids use.
TEF presentations are variable and depend in many cases on the size of the fistula
and the amount of the gastric contents regurged to the airway. TEF may be discovered by the
treating team while the patient on mechanical ventilator in cases the enteral food materials are
aspirated from the ETT during suctioning. Physician might also notice that the patient’s abdo-
men is distended with air; positive endotracheal cuff leaks might also be the pointer toward
the diagnosis. On the other hand, the patients might present after extubation with choking and
coughing with feedings, copious secretions, progressive dyspnea and recurrent episodes of
aspiration pneumonia and/or recurrent hypoxemic events [80].
Once the condition is suspected clinically it can be confirmed by imaging. CT scan
or esophagograph with barium or gastrografin contrast can be used. The communicating
fistulous tract can directly be visualized during Esophagogastroduodenoscopy (EGD) or bron-
choscopy. A small or high up fistulas might be missed during bronchoscopy; therefore, bron-
choscopist should pull the ETT up and meticulously search the fistula [81]. Bronchoscopic
signs of fistula include redness and swollen of the mucosa and/or presence of whitish material
in the airway [81].
Spontaneous closure of the fistula is rare; therefore, once a TEF has been identified a prompt
medical intervention should be undertaken as a bridge until the patient general condition
improves to allow for definitive surgical interventions. The following management’s steps are
absolutely necessary [82]:
1. Prompt diagnosis and treatment of the aspiration pneumonia, using broad spectrum
antibiotics which cover Gram positive and negative pathogens as well as the anaerobes.
2. A tracheostomy tube should be inserted so that its cuff to be below the fistula. If this is not
possible, the ETT cuff to be placed distal to the fistula; its cuff should be inflated with
minimal pressure.
3. Insertion of a jejunostomy tube for feeding or using total parenteral nutritions (TBN).
4. Gastrostomy tube insertion to reduce gastric contents reflux to the airway.
Surgical repair is the definitive treatment for most cases of intubation induced TEF.
The TEF repair surgeries are high risk surgeries with a mortality rate of 10.9%; the
recurrent rate of the fistulas is 7.9% and post-operative delayed tracheal stenosis has
been reported to occur on 2.6% [82]. Endoscopic closure of small fistula, or inoperable
ones using fibrin glue [81], cardiac septal defect occluders [83] or silicon rings [84] have
been reported in few case reports. Single or dual esophageal and/or tracheal stent place-
ment has been used for palliation in cases where TEF is resulted from malignant under-
lying diseases [81].
5.5. Tracheoarterial fistula
The term tracheoarterial fistula describes an abnormal communication between the tracheo-
bronchial tree and blood vessels. The innominate artery is the most affected vascular structure
(72% of the reported cases) due to its close anatomical proximity to the trachea (Figure 7). The
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incidence of trachea-innominate fistula has been reported to be 0.7% of patient underwent
tracheostomy [85]. Fistulas were also reported to occur between the trachea and the carotid
arteries in 4.3% and between the trachea and the superior and inferior thyroid artery in 0.9 and
2.6% of the cases respectively [86]. It was also reported with aortic aneurysm (1.8%), or even
with a venous structure as the right innominate vein <3.5% [86].
Low lying tracheostomy tube insertion is the major risk for this devastating complication [86].
Tracheoinnominate fistula can also be caused by ETT due to high cuff pressure [87]. Tracheal
mucosa erosion can occur with cuff pressure as low as 25 mm Hg and as early as 24–48 h after
tube placement [88, 89]. Other possible risk factors along with high cuff pressure are:
1. Inappropriate cuff size [87].
2. Neuromuscular disorders as (cerebral palsy, myoclonus epilepsy, agenesis of the corpus
callosum, cerebral contusion, muscular dystrophy and spinal deformities) because the
need of long-term mechanical ventilation and tracheostomy, as well as the presence of
atypical head and neck positions of the patient [87, 90, 91].
3. Tracheal ring fracture during tracheostomy tube insertion; the tracheal ring fragment can
cause continues mechanical irritation and eventually erode through the wall of innominate
artery [92].
The full-blown presentation of tracheoarterial fistula might be proceeded by warning symp-
toms, such as aspiration of blood during suctioning, bleeding beside the tracheal cannula, or
pulsation of the cannula.
Bronchoscopy, catheter angiography or CTangiography are the investigational tools to localize
the fistula. Nonetheless, a small size fistula can poses diagnostic challenges. In view of almost
certain grave outcome in non-operated patients, non-diagnostic results of the investigations in
presence of high clinical suspicion should not delay the surgical exploration and repair [93].
Figure 8 shows catheter angiography picture of tracheoinnominate fistula.
Figure 7. Coronal CT with intravenous contrast shows the innominate artery lies adjacent to the trachea (A. Touman;
Intubation/Long-Term Complications of Tracheal Intubation).
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Warning signs such as sentinel bleeding or pulsating tracheostomy tube are described
in literature and should be checked and reported despite they are frequently absent.
Tracheoarterial fistula presentation is of massive bleeding. The majority of the cases (72%)
bleed in the first 3 weeks [86], however, bleeding might occur as late as after 20 years [84]. In
cases with massive bleeding hemostasis should be insured before pursuing investigations or
definitive treatment. Hemostasis can be achieved by over inflating the tracheostomy/Endotra-
cheal tube cuff until the bleeding stop [90]. The aspirated blood should be suctioned as
asphyxiation is more likely to cause death than blood exsanguination. Supportive measures
such as intravenous volume replacement to correct hypovolemia, or blood transfusion to
replace the blood loss and optimize oxygen delivery should be given as necessary. The
definitive treatment is surgical; with various techniques that have been described in the
literature. There is always concern while dissecting the innominate artery to cause arterial
insufficiency to the cerebral circulation. Neurological deficit reported to occur in 4.5% of
fistula repair survivor [91]; therefore, cerebral blood flow monitoring during the surgery is
of utmost important [90].
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Figure 8. Angiographic scan of a free contrast agent beside the innominate artery and beside left lateral side of the
tracheal cannula. Courtesy of Richter et al. [92].
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